{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:11:11Z","timestamp":1790712671547,"version":"4.1.0"},"reference-count":61,"publisher":"Impact Journals, LLC","issue":"51","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,20]]},"DOI":"10.18632\/oncotarget.13319","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T14:47:24Z","timestamp":1478962044000},"page":"84810-84825","source":"Crossref","is-referenced-by-count":22,"title":["Different BCR\/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction"],"prefix":"10.18632","volume":"7","author":[{"given":"Silvia","family":"Bono","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, Universit\u00e0 degli Studi di Firenze, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Lulli","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, Universit\u00e0 degli Studi di Firenze, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito Giuseppe","family":"D'Agostino","sequence":"additional","affiliation":[{"name":"Centre For Integrative Biology (CIBIO), Universit\u00e0 degli Studi di Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico Di","family":"Gesualdo","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, Universit\u00e0 degli Studi di Firenze, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Loffredo","sequence":"additional","affiliation":[{"name":"Centre For Integrative Biology (CIBIO), Universit\u00e0 degli Studi di Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Cipolleschi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, Universit\u00e0 degli Studi di Firenze, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Provenzani","sequence":"additional","affiliation":[{"name":"Centre For Integrative Biology (CIBIO), Universit\u00e0 degli Studi di Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Rovida","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, Universit\u00e0 degli Studi di Firenze, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persio Dello","family":"Sbarba","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cMario Serio\u201d, Universit\u00e0 degli Studi di Firenze, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,12]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1172\/JCI68951","article-title":"PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells","volume":"123","author":"Zhang","year":"2013","journal-title":"J Clin Invest"},{"key":"2","doi-asserted-by":"publisher","first-page":"21918","DOI":"10.18632\/oncotarget.4204","article-title":"Curcumin inhibitsandchronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21","volume":"6","author":"Alessandro","year":"2015","journal-title":"Oncotarget"},{"key":"3","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2013-07-511907","article-title":"Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition","volume":"123","author":"Ong","year":"2014","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.4161\/15384101.2014.964107","article-title":"The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy","volume":"13","author":"Sbarba","year":"2014","journal-title":"Cell Cycle"},{"key":"5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/ijh.13.32","article-title":"Targeting hypoxia in the leukemia microenvironment","volume":"2","author":"Wilson","year":"2013","journal-title":"Int J Hematol Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V82.7.2031.2031","article-title":"The role of hypoxia in the maintenance of hematopoietic stem cells","volume":"82","author":"Olivotto","year":"1993","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jcp.21690","article-title":"Hypoxia ornormoxia: The stem cell paradigm","volume":"219","author":"Ivanovic","year":"2009","journal-title":"J Cell Physiol"},{"key":"8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0301-472X(01)00765-2","article-title":"Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells","volume":"30","author":"Dello Sbarba","year":"2002","journal-title":"Exp Hematol"},{"key":"9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1634\/stemcells.2006-0637","article-title":"Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells","volume":"25","author":"Dello Sbarba","year":"2007","journal-title":"Stem Cells"},{"key":"10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcp.21908","article-title":"The hematopoietic stem cell niche: low in oxygen but a nice place to be","volume":"222","author":"Jonsson","year":"2010","journal-title":"J Cell Physiol"},{"key":"11","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.leu.2404224","article-title":"Hypoxia suppresses BCR\/Abl and selects imatinib-insensitive progenitors within clonal CML populations","volume":"20","author":"Dello Sbarba","year":"2006","journal-title":"Leukemia"},{"key":"12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3324\/haematol.2010.029082","article-title":"Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate","volume":"96","author":"Dello Sbarba","year":"2011","journal-title":"Haematologica"},{"key":"13","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/leu.2010.101","article-title":"BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase\/blast crisis CML patients","volume":"24","author":"Gambacorti-Passerini","year":"2010","journal-title":"Leukemia"},{"key":"14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","article-title":"Functions of site-specific histone acetylation and deacetylation","volume":"76","author":"Grunstein","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/embo-reports\/kvf053","article-title":"Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics","volume":"3","author":"Becker","year":"2002","journal-title":"EMBO reports"},{"key":"16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nmeth.1314","article-title":"SUnSET, a nonradioactive method to monitor protein synthesis","volume":"6","author":"Pierre","year":"2009","journal-title":"Nat Methods"},{"key":"17","doi-asserted-by":"crossref","first-page":"ra4","DOI":"10.1126\/scisignal.2004331","article-title":"Antipsychotics activate mTORC1-dependent translation to enhance neuronal morphological complexity","volume":"7","author":"Chao","year":"2014","journal-title":"Sci Signal"},{"key":"18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nsb1015","article-title":"Homodirectional changes in transcriptome composition and mRNA translation induced by rapamycin and heat shock","volume":"10","author":"Hentze","year":"2003","journal-title":"Nat Struct Biol"},{"key":"19","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1080\/15548627.2015.1085742","article-title":"Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux","volume":"11","author":"Mograbi","year":"2015","journal-title":"Autophagy"},{"key":"20","first-page":"542","article-title":"How to Interpret LC3 Immunoblotting","volume":"3","author":"Yoshimori","year":"2014","journal-title":"Autophagy"},{"key":"21","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood-2011-01-330621","article-title":"Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML","volume":"118","author":"Holyoake","year":"2011","journal-title":"Blood"},{"key":"22","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1021\/pr0704128","article-title":"Comparative proteome profiling and functional analysis of chronic myelogenous leukemia cell lines","volume":"6","author":"De Leo","year":"2007","journal-title":"J Proteom Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1128\/MCB.11.4.1854","article-title":"Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines","volume":"11","author":"Denny","year":"1991","journal-title":"Mol Cell Biol"},{"key":"24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Weissman","year":"2004","journal-title":"N Engl J Med"},{"key":"25","doi-asserted-by":"publisher","first-page":"36382","DOI":"10.18632\/oncotarget.8871","article-title":"Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR\/ABL axis","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12943-015-0407-0","article-title":"BCR\/ABL1 and BCR are under the transcriptional control of the MYC oncogene","volume":"14","author":"Gambacorti-Passerini","year":"2015","journal-title":"Mol Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2141.2005.05873.x","article-title":"P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors","volume":"132","author":"Santucci","year":"2006","journal-title":"Br J Haematol"},{"key":"28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/bjc.2014.335","article-title":"beta-Arrestin1 promotes the progression of chronic myeloid leukaemia by regulating BCR\/ABL H4 acetylation","volume":"111","author":"Zou","year":"2014","journal-title":"Br J Cancer"},{"key":"29","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","article-title":"MYC-induced cancer cell energy metabolism and therapeutic opportunities","volume":"15","author":"Gao","year":"2009","journal-title":"Clin Cancer Res"},{"key":"30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00424-005-1413-7","article-title":"Hypoxia-responsive transcription factors","volume":"450","author":"Taylor","year":"2005","journal-title":"Pflugers Arch"},{"key":"31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/bj3120163","article-title":"A hierarchy of ATP-consuming processes in mammalian cells","volume":"312","author":"Brand","year":"1995","journal-title":"Biochem J"},{"key":"32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.molcel.2010.09.028","article-title":"Translational regulation of gene expression during conditions of cell stress","volume":"40","author":"Willis","year":"2010","journal-title":"Mol Cell"},{"key":"33","first-page":"128","article-title":"Cap-Independent Translational Control of Carcinogenesis","volume":"6","author":"Thompson","year":"2016","journal-title":"Front Oncol"},{"key":"34","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood-2009-10-249623","article-title":"Bag1 directly routes immature BCR-ABL for proteasomal degradation","volume":"116","author":"Maru","year":"2010","journal-title":"Blood"},{"key":"35","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/mnfr.201200167","article-title":"Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr\/Abl","volume":"56","author":"Chang","year":"2012","journal-title":"Mol Nutr Food Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2141.2002.03468.x","article-title":"p53 expression in K562 cells is associated with caspase-mediated cleavage of c-ABL and BCR-ABL protein kinases","volume":"117","author":"Cotter","year":"2002","journal-title":"Br J Haematol"},{"key":"37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1582-4934.2002.tb00309.x","article-title":"Regulation of apoptosis by the ubiquitin and proteasome pathway","volume":"6","author":"Wojcik","year":"2002","journal-title":"J Cell Mol Med"},{"key":"38","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/sj.leu.2402201","article-title":"Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an approximately 700 kDa Apaf-1 containing apoptosome complex","volume":"15","author":"Cohen","year":"2001","journal-title":"Leukemia"},{"key":"39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/B:APPT.0000018793.10779.dc","article-title":"The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodeling","volume":"9","author":"McLaughlin","year":"2004","journal-title":"Apoptosis"},{"key":"40","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/onc.2010.561","article-title":"Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis","volume":"30","author":"Rathmell","year":"2011","journal-title":"Oncogene"},{"key":"41","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1080\/15384101.2015.1078029","article-title":"Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells","volume":"14","author":"Dello Sbarba","year":"2015","journal-title":"Cell Cycle"},{"key":"42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4161\/cc.7.2.5315","article-title":"Environmental restrictions within tumor ecosystems select for a convergent, hypoxia-resistant phenotype of cancer stem cells","volume":"7","author":"Dello Sbarba","year":"2008","journal-title":"Cell Cycle"},{"key":"43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"44","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/2159-8290.CD-15-0439","article-title":"Evolutionary determinants of cancer","volume":"5","author":"Greaves","year":"2015","journal-title":"Cancer Discov"},{"key":"45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrclinonc.2015.208","article-title":"Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era","volume":"13","author":"Novelli","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"46","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1038\/ncomms7367","article-title":"The reverse evolution from multicellularity to unicellularity during carcinogenesis","volume":"6","author":"He","year":"2015","journal-title":"Nat Commun"},{"key":"47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/molbev\/msv212","article-title":"The Convergent Cancer Evolution toward a Single Cellular Destination","volume":"33","author":"He","year":"2016","journal-title":"Mol Biol Evol"},{"key":"48","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1182\/blood-2014-09-601062","article-title":"Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL","volume":"125","author":"Sherr","year":"2015","journal-title":"Blood"},{"key":"49","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.2174\/1381612811319300006","article-title":"The Culture-Repopulating Ability assays and incubation in low oxygen: a simple way to test drugs on leukaemia stem or progenitor cells","volume":"19","author":"Dello Sbarba","year":"2013","journal-title":"Curr Pharm Des"},{"key":"50","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Druker","year":"2011","journal-title":"J Clin Invest"},{"key":"51","first-page":"106","article-title":"Do we need more drugs for chronic myeloid leukemia?","volume":"263","author":"Helgason","year":"2014","journal-title":"Immunol Rev"},{"key":"52","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Sawyers","year":"2001","journal-title":"Science"},{"key":"53","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Holyoake","year":"2006","journal-title":"Blood"},{"key":"54","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1182\/blood-2008-06-164582","article-title":"Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD\/SCID repopulating cells","volume":"115","author":"Holyoake","year":"2010","journal-title":"Blood"},{"key":"55","doi-asserted-by":"crossref","first-page":"e77390","DOI":"10.1371\/journal.pone.0077390","article-title":"Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells","volume":"8","author":"Khosravi-Far","year":"2013","journal-title":"PLoS One"},{"key":"56","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1038\/oncsis.2014.3","article-title":"Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models","volume":"3","author":"Irvine","year":"2014","journal-title":"Oncogenesis"},{"key":"57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2012.03.014","article-title":"Regulation of apoptosis pathways in cancer stem cells","volume":"338","author":"Fulda","year":"2013","journal-title":"Cancer Lett"},{"key":"58","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Hunter","year":"2009","journal-title":"J Clin Invest"},{"key":"59","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1038\/cddis.2013.49","article-title":"AML1\/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia. Cell death & disease","volume":"4","author":"Dello Sbarba","year":"2013","journal-title":"Cell Death Dis"},{"key":"60","doi-asserted-by":"crossref","first-page":"16478","DOI":"10.1038\/srep16478","article-title":"Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function","volume":"5","author":"Provenzani","year":"2015","journal-title":"Sci Rep"},{"key":"61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0076-6879(07)31006-9","article-title":"Methods to Analyze MicroRNA-Mediated Control of mRNA Translation","volume":"431","author":"Preiss","year":"2007","journal-title":"Methods Enzymol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T14:28:21Z","timestamp":1596724101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,12]]},"references-count":61,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2016,12,20]]}},"alternative-id":["13319","27852045"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13319","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,12]]}}}